Korean Market
ISSU
Neuromeka
★★

Neuromeka Decides on 126.6B KRW Rights Offering at 39,600 KRW per Share... Largest Shareholder Stake May Drop to 14.67%, Raising Dilution Concerns

 
MATR
Neuromeka
★

Neuromeka Announces 126.58B KRW Rights Offering and 50% Stock Dividend - Discounted Issue Price of 39,600 KRW, Risks of Dilution and Price Decline

 
OWNR
Neuromeka
★

Master Heo Yeong-jin Exercises Stock Options, Stake Slightly Increases to 0.61%... Limited Impact on Minority Shareholders

 
OWNR
Neuromeka
★

Neuromeka Non-Registered Director Jeong Jong-pil Acquires 7,000 Additional Shares via Stock Option Exercise… Minor Ownership Change, Limited Impact on Shareholder Value

 
OWNR
Neuromeka
★

Neuromeka Non-Registered Officer Lee Jae-cheon Increases Stake to 0.18% via Stock Option Exercise… Profits from Low Exercise Price

 
OWNR
Neuromeka
★

Mirae Asset Global Investments Increases Stake in Neuromeka to 5.07% (11,990 Shares via ETF Creation)

 
ISSU
Neuromeka
★★★

Neuromeka Announces 150 Billion KRW Rights Offering - Aimed at Financial Restructuring and Facility Investment, Significant Dilution Risk

 
PERI
Neuromeka
★

Neuromeka: Q1 Operating Loss Continues, but Debt Ratio Sharply Improves to 101% Following CB Conversion

 
EXCH
Neuromeka
★

Decision to Increase Short-term Borrowing by KRW 10 Billion

 
OWNR
Neuromeka
★

Submission of Mass Holdings Report (Simplified Form)